Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 21, 2018; 24(27): 3038-3054
Published online Jul 21, 2018. doi: 10.3748/wjg.v24.i27.3038
Published online Jul 21, 2018. doi: 10.3748/wjg.v24.i27.3038
Algeria | Djibouti | Egypt | Libya | Morocco | Sudan | Tunisia | Pakistan | |
Blood donors | 0.2% (1992-1993)1 | 0.3% (1998-2000)1 | 1.7%-16.8% (2006-2009)1 | 0.9%-6.6% (1992-2001)1 | 0.2%-0.8% (2005-2011)1 | 0.0%-1.3% (2005-2007)1 | 0.1%-0.9% (2000-2010)1 | 0.2%-8.6% (2000-2006)1 |
Pregnant women | 0.6% (2008)1 | No data | 8.6%-12.7% (-)3 | 0.4%-2.3% (-)3 | 1.0% (-)2 | 0.6% (2006)1 | 0.2% (2006)1 | 5.3% (2001-2006)1 |
Children | No data | No data | 2.1%-5.8% (2002-2005)1 | No data | No data | No data | No data | 1.7% (-)2 |
Hemodialysis, renal dialysis, and/or dialysis patients | 39.0% (-)3 | No data | 46.1%-100% (2002-2009)1 | 32.3% (2009-2010)1 | 54.1%-68.3% (2003-2004)1 | 8.5%-23.7% (2005-2010)1 | 14.6%-32.6% (2000-2002)1 | 38.8% (2003-2005)1 |
Hemophiliac or other bleeding disorder patients | 30.0% (2010-2011)2 | No data | No data | No data | 2.3%-42.4% (1981-2006)1 | 13.0% (2008)2 | 55.7% (-)2 | 25.0%-56.0% (2000-2002)1 |
Transfused patients | No data | No data | 11.1%-81.6% (2000-2008)1 | 10.8% (1999-2001)1 | No data | No data | 4.7% (2008-2009)1 | 13.2%-15.4% (2002)1 |
Thalassemic patients | No data | No data | 19.5%-69.6% (2000-2010)1 | No data | 68.3%-76.0% (-)3 | No data | 6.1% (-)2 | 36.2-56.8% (1999-2003)1 |
Patients with hepatocellular carcinoma | No data | No data | 85.9% (1997-2004)1 | No data | 57.3% (2003-2006)2 | 11.0% (1996-1998)1 | 19.0%-63.5% (1982-< 1995)2 | 53.7% (-)2 |
Patients with acute liver disease | No data | No data | No data | No data | 0.0% (1999)1 | 6.3% (2007)2 | 8.0%-48.0% (< 1995)3 | No data |
Patients with chronic liver disease | No data | No data | No data | No data | 73.7% (1983-1986)2 | No data | 80.5% (2005-2008)2 | 0.0%-86.6% (2000-2005)1 |
Healthcare workers | No data | No data | No data | 2.0%-6.8% (1992-2001)1 | No data | 0.0% (2005-2007)1 | 1.0% (2005)1 | 5.6%-6.0% (2001-2002)1 |
Barbers | No data | No data | 12.3% (-)3 | No data | 1.1%-5.0% (2001-2007)1 | No data | No data | No data |
Contact of patients with hepatitis C | No data | No data | No data | No data | No data | No data | No data | 4.3%-38.0% (2000-2004)1 |
People who inject drugs | No data | No data | 63.0% (-)2 | 94.2% (2010)1 | 22.9%-79.2% (2010-2012)1 | No data | 21.7%-29.1% (2009-2012)1 | 57.0% (-)2 |
Prisoners | No data | No data | No data | 23.7% (2006)1 | No data | No data | No data | No data |
Patients with HIV and/or other sexually transmitted infection | No data | No data | No data | 44.9%-54.1% (2003)1 | 5.4% (2006-2010)1 | 1.7% (2010-2012)1 | 35.5% (1997-2006)1 | No data |
Sex workers | No data | No data | No data | 5.2%-7.3% (2010-2011)1 | No data | 0.0%-5.1% (2011-2012)1 | 1.1% (2007)1 | No data |
Men who have sex with men | No data | No data | No data | No data | No data | 0.0%-5.9% (2011-2012)1 | No data | No data |
- Citation: Chaabna K, Cheema S, Abraham A, Alrouh H, Lowenfels AB, Maisonneuve P, Mamtani R. Systematic overview of hepatitis C infection in the Middle East and North Africa. World J Gastroenterol 2018; 24(27): 3038-3054
- URL: https://www.wjgnet.com/1007-9327/full/v24/i27/3038.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i27.3038